UNSPSC 51241522: Dorzolamide/timolol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP105. This VA Drug Class (OP105) classifies this compound as belonging to the group ANTIGLAUCOMA COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51241522 Dorzolamide/timolol is a Commodity code covering a fixed-combination ophthalmic medication used to treat elevated intraocular pressure in glaucoma and ocular hypertension. State and local governments procure this drug primarily through health departments, corrections departments, and public health clinics that provide direct patient care or maintain formularies for covered populations. The medication combines a carbonic anhydrase inhibitor (dorzolamide) with a beta-blocker (timolol) in a single topical formulation, reducing dosing burden and improving compliance in clinical settings where generic or branded versions are stocked as part of standing pharmaceutical inventories.

The source provided contains no recent state and local contract opportunities tagged to this code, and therefore no data on issuing-body concentration, geographic spread, or representative recent solicitations.